FSCN1 and neoplasm: Collectively considerated, tumours with high (>60%) fascin immunoreactivity showed significantly greater Ki-67 labelling index (mean±s.d.: 27.9±16.5%; median: 27%) than tumours with negative to low (up to 30%) fascin immunoreactivity (mean±s.d.: 20.4±13.4%; median: 20%) (P=0.028).